U.S. Liquid Embolic Agent Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Ethylene Vinyl Alcohol Copolymer, Cyanoacrylates), By Application (AVM, Hypervascular Tumors), By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Application
                        1.2.3. End Use
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                        1.5.5. Information Analysis
                        1.5.6. Data Analysis Models
                    1.6. Market Formulation & Data Visualization
                    1.7. Model Details
                        1.7.1. Commodity Flow Analysis
                    1.8. List of Secondary Sources
                    1.9. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Liquid Embolic Agent Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Increasing incidence of conditions such as arteriovenous malformations (AVMs), aneurysms, and hemorrhages necessitates embolization procedures
                            3.2.1.2. Advancements in embolization technologies
                            3.2.1.3. Increasing adoption in oncology treatments
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. High cost of materials and procedures
                            3.2.2.2. Strict regulatory approvals and compliance
                        3.2.3. Market Opportunities Analysis
                            3.2.3.1. Emerging applications
                        3.2.4. Market Challenges Analysis
                    3.3. U.S. Liquid Embolic Agent Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Bargaining power of suppliers
                            3.3.1.2. Bargaining power of buyers
                            3.3.1.3. Threat of substitutes
                            3.3.1.4. Threat of new entrants
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political & Legal Landscape
                            3.3.2.2. Economic and Social Landscape
                            3.3.2.3. Technological landscape
Chapter 4. U.S. Liquid Embolic Agent Market: Product Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Liquid Embolic Agent Market Product Movement Analysis
                    4.3. U.S. Liquid Embolic Agent Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
                    4.4. Ethylene Vinyl Alcohol Copolymer (EVOH)
                        4.4.1. Ethylene Vinyl Alcohol Copolymer (EVOH) U.S. Liquid Embolic Agent Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    4.5. Cyanoacrylates
                        4.5.1. Cyanoacrylates U.S. Liquid Embolic Agent Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.5.2. N-BCA
                            4.5.2.1. N-BCA U.S. Liquid Embolic Agent Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.5.3. N-HCA
                            4.5.3.1. N-HCA U.S. Liquid Embolic Agent Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    4.6. Others
                        4.6.1. Others U.S. Liquid Embolic Agent Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Liquid Embolic Agent Market: Application Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Liquid Embolic Agent Market Application Movement Analysis
                    5.3. U.S. Liquid Embolic Agent Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
                    5.4. Arteriovenous Malformations (AVM)
                        5.4.1. Arteriovenous Malformations (AVM) U.S. Liquid Embolic Agent Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    5.5. Hypervascular Tumors
                        5.5.1. Hypervascular Tumors U.S. Liquid Embolic Agent Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    5.6. Peripheral Vasculature Hemorrhage
                        5.6.1. Peripheral Vasculature Hemorrhage U.S. Liquid Embolic Agent Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    5.7. Others
                        5.7.1. Others U.S. Liquid Embolic Agent Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Liquid Embolic Agent Market: End Use Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. U.S. Liquid Embolic Agent Market End Use Movement Analysis
                    6.3. U.S. Liquid Embolic Agent Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
                    6.4. Hospitals
                        6.4.1. Hospitals U.S. Liquid Embolic Agent Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.5. Specialty Clinics
                        6.5.1. Specialty Clinics U.S. Liquid Embolic Agent Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.6. Ambulatory Surgery Centers
                        6.6.1. Ambulatory Surgery Centers U.S. Liquid Embolic Agent Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.7. Other End Use
                        6.7.1. Other End Use U.S. Liquid Embolic Agent Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Market Participant Categorization
                    7.2. Key Company Profiles
                        7.2.1. Medtronic
                            7.2.1.1. Company Overview
                            7.2.1.2. Financial Performance
                            7.2.1.3. Product Benchmarking
                            7.2.1.4. Strategic Initiatives
                        7.2.2. Terumo
                            7.2.2.1. Company Overview
                            7.2.2.2. Financial Performance
                            7.2.2.3. Product Benchmarking
                            7.2.2.4. Strategic Initiatives
                        7.2.3. Boston Scientific Corporation
                            7.2.3.1. Company Overview
                            7.2.3.2. Financial Performance
                            7.2.3.3. Product Benchmarking
                            7.2.3.4. Strategic Initiatives
                        7.2.4. Johnson & Johnson
                            7.2.4.1. Company Overview
                            7.2.4.2. Financial Performance
                            7.2.4.3. Product Benchmarking
                            7.2.4.4. Strategic Initiatives
                        7.2.5. Sirtex (BlackSwan Vascular, Inc.)
                            7.2.5.1. Company Overview
                            7.2.5.2. Financial Performance
                            7.2.5.3. Product Benchmarking
                            7.2.5.4. Strategic Initiatives
                        7.2.6. Others
                            7.2.6.1. Company Overview
                            7.2.6.2. Financial Performance
                            7.2.6.3. Product Benchmarking
                            7.2.6.4. Strategic Initiatives
                    7.3. Company Market Share Analysis, 2024
                    7.4. List of Other Key Market Players

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. U.S. Liquid Embolic Agent Market, by Product, 2021 - 2033 (USD Million)
Table 4. U.S. Liquid Embolic Agent Market, by Application, 2021 - 2033 (USD Million)
Table 5. U.S. Liquid Embolic Agent Market, by End Use, 2021 - 2033 (USD Million)
Table 6. Participant’s Overview
Table 7. Financial Performance
Table 8. Product Benchmarking
Table 9. Strategic Initiatives

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 U.S. Liquid Embolic Agent Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 Market Opportunity Analysis (Current & Future Impact)
Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 11 Porter’s Five Forces Analysis
Fig. 12 Regional Marketplace: Key Takeaways
Fig. 13 U.S. Liquid Embolic Agent Market, for Product, 2021 - 2033 (USD Million)
Fig. 14 U.S. Liquid Embolic Agent Market, for Ethylene Vinyl Alcohol Copolymer (EVOH), 2021 - 2033 (USD Million)
Fig. 15 U.S. Liquid Embolic Agent Market, for Cyanoacrylates, 2021 - 2033 (USD Million)
Fig. 16 U.S. Liquid Embolic Agent Market, for N-BCA, 2021 - 2033 (USD Million)
Fig. 17 U.S. Liquid Embolic Agent Market, for N-HCA, 2021 - 2033 (USD Million)
Fig. 18 U.S. Liquid Embolic Agent Market, for Others, 2021 - 2033 (USD Million)
Fig. 19 U.S. Liquid Embolic Agent Market, for Arteriovenous Malformations (AVM), 2021 - 2033 (USD Million)
Fig. 20 U.S. Liquid Embolic Agent Market, for Hypervascular Tumors, 2021 - 2033 (USD Million)
Fig. 21 U.S. Liquid Embolic Agent Market, for Peripheral Vasculature Hemorrhage, 2021 - 2033 (USD Million)
Fig. 22 U.S. Liquid Embolic Agent Market, for Others, 2021 - 2033 (USD Million)
Fig. 23 U.S. Liquid Embolic Agent Market, for End Use, 2021 - 2033 (USD Million)
Fig. 24 U.S. Liquid Embolic Agent Market, for Hospitals, 2021 - 2033 (USD Million)
Fig. 25 U.S. Liquid Embolic Agent Market, for Specialty Clinics, 2021 - 2033 (USD Million)
Fig. 26 U.S. Liquid Embolic Agent Market, for Ambulatory Surgery Centers, 2021 - 2033 (USD Million)
Fig. 27 U.S. Liquid Embolic Agent Market, for Other End Use, 2021 - 2033 (USD Million)